GLP-1 Medications Show Little Effect on Cancer, Study Shows

A new study suggests popular GLP-1 drugs, like Ozempic and Zepbound, may not lower cancer risk as some had hoped.

Researchers analyzed 48 randomized trials including 94,245 adults who were overweight, obese or had type 2 diabetes. More than 51,000 people took a GLP-1 drug, and nearly 43,000 received a placebo and were followed for about 70...

Opioid Use Linked to Higher Risk of C. Diff Infection, Study Finds

Taking opioids may make some patients more likely to develop a dangerous infection, new research suggests.

The infection is called Clostridioides difficile, or C. diff. It affects the colon and can spread easily, especially in hospitals and nursing homes. The illness can cause severe diarrhea, stomach pain, nausea and vom...

CDC Delays Annual Abortion Report Amid Internal Turmoil

For decades, the U.S. Centers for Disease Control and Prevention (CDC) has released a yearly report tracking abortion trends across the country.

But this year’s report has been delayed until spring, and the agency says internal changes and staffing issues are to blame.

The report is usually released in late November and include...

Many Young Americans Still Smoking Tobacco and Cannabis, Study Shows

Many young Americans are still smoking nicotine, tobacco or cannabis, even as edibles and vapes continue to grow in popularity.

A University of Michigan study looked at how 12- to 34-year-olds are using these substances today. Researchers examined data from 8,722 individuals who had used at least one of these products within the last 30 da...

AI Can Improve Epilepsy Treatment, Experts Argue

Artificial intelligence (AI) can help improve treatment of epilepsy by connecting the dots in complex cases, a new study says.

AI helped identify patients with drug-resistant epilepsy who might benefit from surgery, and it highlighted missing tests and evaluations that could better guide patients’ care, researchers reported in Atlant...

U.S. ERs Are Failing Sickle Cell Patients In Pain, Study Says

U.S. emergency rooms are failing patients in severe pain from a sickle cell disease crisis, a new study says.

Only 1 in 3 patients in an ER for sickle cell crisis receive opioid painkillers within the first hour as treatment guidelines recommend, researchers reported Saturday in Orlando at an American Society of Hematology meeting.

A...